Navigation Links
Dr. Michael Brownlee receives JDRF Rumbough Award for Scientific Excellence
Date:5/19/2008

May 19, 2008 (BRONX, NY) Michael Brownlee, M.D., the Anita and Jack Saltz Professor of Diabetes Research at Albert Einstein College of Medicine of Yeshiva University, has been selected by the Juvenile Diabetes Research Foundation (JDRF) to receive the prestigious David Rumbough Award for Scientific Excellence. The award recognizes researchers for their outstanding achievement and commitment to diabetes research. Actress Dina Merrill established this award in 1974 in honor of her late son, David.

Upon the presentation of the award, Ms. Merrill noted, I am honored to join with you tonight in the presentation of the David Rumbough Award for Scientific Excellence, which was established in honor of my late, beloved son, David. He would have been very pleased to know that research towards a cure is progressing rapidly and improving the lives of so many. Keep up the good work.

Dr. Brownlee is one of the most respected and influential scientists in his field and is noted for his innovative approach to understanding the biochemical basis of diabetic complications. He is internationally recognized for his research including his discovery of a novel molecular pathway linking hyperglycemia to diabetic retinopathy, a complication of the disease.

His propensity for creative exploration has also led to other notable contributions to the field of knowledge in understanding type 1 diabetes and its complications. For example, through his studies, Dr. Brownlee has established that the four seemingly independent biochemical pathways found to contribute to hyperglycemia-induced damage in type 1 diabetes polyol pathway activation, advanced glycation endproduct (AGE) formation, protein kinase C (PKC), and hexosamine pathway activation all arise from a single hyperglycemia-induced process that is initiated by overproduction of toxic free radicals produced by the cells mitochondria. He also has demonstrated that normalizing free-radical levels inhibits the pathways through which cell damage occurs. And, his research of benfotiamine, a synthetic derivative of the dietary supplement thiamine (vitamin B1), found that it blocked all major pathways of hyperglycemic damage, and that it blocked formation of structural lesions in the retinas of long-term diabetic animals. His current studies include clinical trials of benfotiamine.

Dr. Brownlee also is the Director of the JDRF International Center for Diabetic Complications Research at Einstein. All of the projects in this Center share an overriding aim: to develop innovative, highly effective therapies for preventing the development and progression of retinopathy, nephropathy, neuropathy, and atherosclerosis in type 1 patients.

In 2006, JDRF awarded Dr. Brownlee with its Scholar Award. His contributions to the field have also been extensively recognized through his receipt of other prestigious awards, including the 2005 Naomi Berrie Award for Outstanding Achievement in Diabetes Research from Columbia University Medical Center; the 2004 Banting Medal, the highest scientific award of the American Diabetes Association; the 2004 Davis Award from the Childrens Diabetes Foundation; the 2003 Claude Bernard Medal, the highest scientific honor given by the European Association for the Study of Diabetes; and the 1993 Outstanding Scientific Achievement Award, presented by the American Diabetes Association.

In addition to Dr. Brownlee, a 2008 JDRF Rumbough Award also was presented to Dr. Michael German, of the University of California San Francisco.


'/>"/>

Contact: Karen Gardner
kgardner@aecom.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related medicine news :

1. Michael A. Sandler, MD, Installed as President of Michigan State Medical Society
2. Mylan Appoints Michael J. Monroe Senior Vice President for Global Public Affairs
3. Michael E. DeBakey Receives Congressional Gold Medal
4. Consumers Research Council of America Names Pediatrician Michael Y. Wu, MD, MBA as One of Americas Top Pediatricians
5. Childhood Obesity Expert Dr. William Dietz Featured at the 2nd Annual Michael & Susan Dell Lectureship in Child Health
6. Michael D. Farley Appointed Chief Operating Officer of Lupus Foundation of America, Inc.
7. Michael J. Fox Foundation Commits Up to $2 Million to Improve Drug Delivery for Parkinsons Disease
8. Michael A. Giaquinto to Join Greenhill as a Managing Director
9. STERIS Corporation Names Michael J. Tokich Chief Financial Officer
10. Cardinal Health Names Michael C. Kaufmann to Lead Pharmaceutical Segment
11. Cultivating the Smart Patient: Author and RealAge Founder Michael F. Roizen, MD to Present Keynote at URAC Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... , ... September 19, 2017 , ... Public outrage over ... pollutants have fallen on deaf ears, leaving the water industry itself to research, develop ... stays ahead of the curve in the field of natural alkaline water ...
(Date:9/19/2017)... ... ... Bone Solutions Inc. (BSI), an orthobiologics technology company located ... OsteoCrete® bone void filler is designed to assist with bone repair and generation, ... for bone health and development. , “We’re excited to bring this important orthopedic ...
(Date:9/19/2017)... ... September 19, 2017 , ... Ron Norman, CEO of ... the importance of making a distinct rather than generic impression in the job market ... look through a stack of resumes knows that the first impression they give off ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency ... the Certified Emergency Nurse (CEN®) certification according to a large-scale study ... of certification study, conducted by the Human Resources Research Organization (HumRRO) in late ...
(Date:9/18/2017)... ... 2017 , ... A September 7 article on BBC News describes ... the world’s most common and least expensive medications, may be able to stimulate stem ... of California Dental Group and Calabasas Dental Care says that, while it’s likely to ...
Breaking Medicine News(10 mins):
(Date:9/1/2017)... Ind. , Sept. 1, 2017  Explorers Like Us ... capture America,s greatest aural experiences — and deliver these experiences ... experience to help people feel and heal better. ... While nothing beats a ... and refresh your mind, Life Environments™ is the next best ...
(Date:8/31/2017)... Aug. 31, 2017 PM360,s annual Innovations ... to the latest innovations happening across the industry. Established ... to focus on providing a comprehensive look at the ... covers the most innovative companies, startups, divisions, products, services, ... "Everyone in this industry wants to ...
(Date:8/29/2017)... In a move that promises to exponentially ... veterinary practices of all sizes, Cubex LLC and The ... TITAN,s expertise in physical security, drug diversion investigations, staff ... "Every veterinary ... is at risk today," said TITAN founder and CEO, ...
Breaking Medicine Technology: